Eldotain Tablets (Erdosteine)

Adult dose

Adults: Administer (take) 300 mg of erdosteine orally 2~3 times daily. When administered for acute respiratory disease, do not administer continuously for more than 10 days.

This medication should not be used in certain patients. Individuals allergic to this medication or its ingredients should not take it. Patients with liver cirrhosis or cystathionine synthase deficiency should avoid this medication as its metabolites can affect methionine metabolism. Patients with peptic ulcers should also avoid this medication. Patients with severe renal impairment, especially those with a creatinine clearance of less than 25 mL/min, should not use this medication. Patients with severe liver impairment should also refrain from taking this medication. Additionally, this medication contains lactose; individuals genetically predisposed to galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication. Patients with mild to moderate liver impairment should use this medication cautiously and should not exceed a dose of 300 mg per day. Patients with diabetes or on a low-calorie diet should be particularly cautious when using syrup formulations. Excessive intake of this medication can lead to symptoms such as sweating, dizziness, and flushing of the face. Neurological and respiratory symptoms have been reported, including headaches, cold symptoms, and shortness of breath. Gastrointestinal side effects can include altered taste, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Dermatological reactions may include hives, red spots, and eczema. Various adverse reactions such as fatigue, dyspepsia, palpitations, facial and general swelling, itching, weakness, drowsiness, and rash have been reported, although a direct correlation with this medication is not established. Taking this medication alongside expectorants may increase the risk of bronchial infections due to difficulty in expelling mucus with the relief of cough. Additionally, this could affect bronchial constriction and dilation, potentially causing bronchospasm, so caution is warranted when combining these medications. Pregnant or potentially pregnant women, as well as nursing mothers, are advised not to take this medication as its safety has not been established. This medication should be stored out of reach of children and precautions should be taken to avoid transferring it to other containers which may lead to accidents or affect the quality of the medication.

• sweating
• dizziness
• flushing
• headache
• cold
• difficulty breathing
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

Consult with your doctor or pharmacist if taking this medication alongside cough medicines.

This medication should be stored in a tightly closed container to avoid exposure to air or moisture, in a safe room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain its efficacy for a longer period.

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle